OPHTHALMIC SURGERY LASERS & IMAGING, vol.34, no.6, pp.451-456, 2003 (SCI-Expanded)
BACKGROUND AND OBJECTIVE: To evaluate the efficacy of intracameral tissue plasminogen activator (tPA) in the treatment of severe fibrinous membranes that do not respond to anti-inflammatory treatment.